AVGO vs NBHC Stock Comparison
AVGO currently leads NBHC in this stock comparison, with AIQ scores of 52 vs 41. The clearest difference is quality, while NBHC has the stronger risk resilience profile.
What is the main difference between AVGO and NBHC?
AVGO leads the current stock comparison as Broadcom Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Broadcom Inc. vs National Bank Holdings Corporation
AVGO leads
AVGO leads by 11 AIQ points, primarily on Quality and Momentum.
Competitive: 4 of 6 evidence groups support AVGO, and its current signal state is conflicted.
Broadcom Inc.
National Bank Holdings Corporation
The Algovestiq AIQ Score currently favors AVGO over NBHC, 52 versus 41 as of Nov 15, 2026. AVGO's advantage is driven primarily by stronger quality and momentum, while NBHC holds the stronger risk resilience profile. AVGO also shows the stronger technical structure relative to its 50-day moving average. 4 of 6 covered evidence groups favor AVGO today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. AVGO lead: Stable — the AIQ differential has held near 11 points over 30 sessions.
Compare Broadcom Inc. and National Bank Holdings Corporation across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare AVGO and NBHC against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Risk Resilience47 vs 83NBHC +36
- Quality69 vs 35AVGO +34
- Momentum40 vs 26AVGO +14
- Value50 vs 41AVGO +9
4 of 6 evidence groups favor AVGO. AVGO’s edge is concentrated in quality and momentum; NBHC keeps a meaningful risk resilience edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Momentum -2, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 6 active signals are unchanged.
Largest factor move: Value -1, not enough on its own to move the overall score.
New signals
- ADX Trend Weakening — neutral, trend, medium horizon
- MACD Bullish Crossover — bullish, momentum, short horizon
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
AVGO's lead was unchanged in the latest session.
Deeper signal detail for each name lives on its own signals page — AVGO and NBHC both carry a full feed there.
The central trade-off
AVGO (Broadcom Inc.): the stronger current systematic profile, led by quality and momentum.
NBHC (National Bank Holdings Corporation): the counter-case, on risk resilience.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
AVGOAVGO on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
AVGOAVGO on combined revenue and EPS growth.
Value
AVGOAVGO on the peer-relative Value factor, by 9 points.
Momentum
AVGOAVGO on the Momentum factor, by 14 points.
Lower downside
NBHCNBHC on Risk Resilience, by 36 points.
Analyst upside
AVGOAVGO on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | AVGO | NBHC | Note |
|---|---|---|---|
| Implied upside to target | +48.5% | +17.8% | AVGO has more room |
| Target dispersion | +48.5% | +4.5% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 51 | 4 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
4 of 6 covered evidence groups favor AVGO. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | AVGO | 52 vs 41 |
| Fundamentals | Even | revenue growth 33.4% vs 41.8%; EPS growth 40.3% vs -129%; gross margin 68.8% vs 69.7%; operating margin 48.4% vs 11.9% |
| Valuation | AVGO | Value 50 vs 41 |
| Technicals | AVGO | Price vs 50-day 0.5% vs -4%; vs 200-day -5.6% vs -9.3% |
| Risk Resilience | NBHC | Risk Resilience 47 vs 83 |
| Analyst expectations | AVGO | Target upside 48.5% vs 17.8% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AVGO and NBHC and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is moderate at 11 points.
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on AVGO.
How the comparison changed
120 daily snapshots · May 27 – Nov 13AVGO lead: Stable — the AIQ differential has held near 11 points over 30 sessions.
- Today
- AVGO +11
- 52 vs 41
- 7 sessions ago
- AVGO +5
- 50 vs 45
- 30 sessions ago
- AVGO +9
- 55 vs 46
- 90 sessions ago
- AVGO +8
- 59 vs 51
The lead changed hands 2 times in this window, most recently on Jun 23 when NBHC moved ahead of AVGO.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 2 bearish / 2 neutral, conflicted
Only AVGO
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.14%)
- Accumulation Pattern — bullish, volume, medium horizon (1.18x)
- Beta Spike Warning — bearish, risk_regime, long horizon
4 bullish / 2 bearish / 2 neutral, conflicted
Only NBHC
- Bollinger Band Squeeze — neutral, volatility, short horizon (7.5%)
- Downtrend Structure Active — bearish, trend, long horizon
- MACD Bullish Crossover — bullish, momentum, short horizon
- OBV Bullish Divergence — bullish, volume, medium horizon (-1.5%)
- RSI Bullish Divergence — bullish, momentum, medium horizon
Both carry 3 more signals that do not separate them: Death Cross Active, ADX Trend Weakening, MACD Histogram Expanding Bullish.
AVGO leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -4.76%, AIQ 0 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.84%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1NBHC closes the Quality gap — currently 34 points behind, the largest single contributor to AVGO's edge.
- 2NBHC's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3AVGO's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
Split| Metric | AVGO | NBHC |
|---|---|---|
| Revenue growth (YoY) | 33.4% | 41.8% |
| EPS growth (YoY) | 40.3% | -129% |
| Gross margin | 68.8% | 69.7% |
| Operating margin | 48.4% | 11.9% |
| Return on equity (TTM) | 13.1% | -0.5% |
| Debt to equity | 0.6 | 0.21 |
Performance
AVGO leads 4 of 6 windows| Metric | AVGO | NBHC |
|---|---|---|
| 1 week (5 sessions) | 18.2% | 1.2% |
| 1 month (20 sessions) | 5.6% | -1.5% |
| 3 months (63 sessions) | -11.6% | -13.6% |
| 6 months (126 sessions) | -18.4% | -8.5% |
| Year to date | 0.3% | -1.7% |
| 1 year (252 sessions) | -2.3% | 0.7% |
Technicals
AVGO has the stronger structure| Metric | AVGO | NBHC |
|---|---|---|
| RSI (14) | 53.2 | 43.8 |
| ADX (14) | 23 | 24.8 |
| Price vs 50-day | 0.5% | -4% |
| Price vs 200-day | -5.6% | -9.3% |
| Volatility (1M, annualized) | 70% | 23.5% |
Risk
NBHC is the more resilient| Metric | AVGO | NBHC |
|---|---|---|
| Beta | 2.21 | 0.44 |
| Sharpe ratio | 0.21 | 0.01 |
| Sortino ratio | 0.29 | 0.02 |
| Max drawdown | -39.5% | -21.6% |
| Current drawdown | -27.9% | -20.7% |
| Annualized volatility | 48.6% | 22.4% |
| Value at risk (95%) | -4.6% | -2.1% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, AVGO or NBHC?
On the Algovestiq AIQ Score, AVGO is the stronger of the two as of Nov 15, 2026, scoring 52 against NBHC's 41. The edge comes from quality and momentum. NBHC is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is AVGO or NBHC the better buy right now?
AVGO carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 4 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor AVGO over NBHC?
The composite weights Quality, Value, Momentum and Risk Resilience. NBHC leads Risk Resilience by 36 points; AVGO leads Quality by 34 points; AVGO leads Momentum by 14 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, AVGO or NBHC?
Analyst price targets imply +48.5% upside for AVGO and +17.8% for NBHC, so the Street currently favors AVGO. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, AVGO or NBHC?
AVGO is the better-valued of the two on the peer-relative Value factor. AVGO on the peer-relative Value factor, by 9 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, AVGO or NBHC?
AVGO on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, AVGO or NBHC?
AVGO on the Momentum factor, by 14 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, AVGO or NBHC?
NBHC is the more resilient of the two, so the other name carries the higher downside risk. NBHC on Risk Resilience, by 36 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is AVGO more profitable than NBHC?
The profitability evidence is mixed: gross margin 68.8% vs 69.7%; operating margin 48.4% vs 11.9%; ttm roe 13.1% vs -0.5%. Each name leads on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is AVGO's lead over NBHC getting stronger or weaker?
AVGO lead: Stable — the AIQ differential has held near 11 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 2 times in that window, most recently on 2026-06-23, when NBHC moved ahead of AVGO.
What would change the AVGO vs NBHC verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: NBHC closes the Quality gap — currently 34 points behind, the largest single contributor to AVGO's edge; NBHC's Death Cross Active resolves — a bearish trend rule currently active against it; AVGO's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about AVGO and NBHC?
AVGO: 2 bullish / 2 bearish / 2 neutral, conflicted. NBHC: 4 bullish / 2 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AVGO is Death Cross Active (bearish, long horizon). On NBHC it is Death Cross Active (bearish, long horizon).
Compare AVGO and NBHC with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.